Devicare
The Digital Therapeutic Company in Urology
The Digital Therapeutic Company in Urology
Devicare is a specialty biotech company founded in 2012 and based in Spain. The company's slogan, "The Digital Therapeutic Company in Urology," reflects its focus on developing innovative medical treatments in Urology. Devicare integrates the latest scientific advances in nutritional therapy with digital technologies, positioning itself at the intersection of Biotechnology, Digital Media, and Health Care industries.
In January 2021, Devicare secured a $3.00M Series A investment, with key investors including Ship2B, Juan Knuth, and EMESA Corporación Empresarial. This funding is poised to propel the company's growth and further advancement of its pioneering medical solutions.
Devicare's commitment to merging medical innovation with digital technologies presents an exciting opportunity for investors and signifies the company's potential to make a significant impact in the urology field through its unique approach to treatment development.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $3.00M | 3 |
|
07 Jan 2021 |
| Equity Crowdfunding | €1.60M | - | 02 Jul 2019 | |
| Debt Financing | €2.00M | 1 | Avançsa | 22 Dec 2017 |
| Debt Financing | €133.00K | 2 | Peroxfarma, ICF Capital | 06 Sep 2017 |
| Seed Round | €3.00M | 6 |
|
05 May 2017 |
No recent news or press coverage available for Devicare.
We care about your data, and we'd love to use cookies make your experience better.
